January 29, 2023
You are here:  Home  >  Regions  >  Central Coast  >  Current Article

Our view: Setbacks are costly but biotech industry copes


Amid a boom in the biotech industry in the Conejo Valley, comes a reminder that drug discovery is expensive and not risk-free. On July 11, Thousand Oaks-based Amgen and partners Novartis, another pharmaceuticals giant, and the Banner Alzheimer’s Institute abruptly halted clinical trials for CNP520, a drug that had shown promise for the prevention of…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.